Analysis of Clinical Characteristics of Patients with Different Types of Primary Hyperuricemia
Download PDF

Keywords

Primary hyperuricemia
Impaired renal excretion
Excessive renal load
Blood test
Urine test
Clinical features

DOI

10.26689/jcnr.v7i5.5266

Submitted : 2023-08-23
Accepted : 2023-09-07
Published : 2023-09-22

Abstract

Objective: This paper aims to study the clinical characteristics of patients with different types of primary hyperuricemia (HUA). Methods: Using a retrospective research method, 200 patients with primary HUA in the hospital from June 2020 to January 2023 were selected as the research objects. Patients were grouped according to the detection results of 24-hour urinary uric acid excretion (UUE) and fractional excretion of uric acid (FEUA) (renal insufficiency type, renal overload type, mixed type, and other types). The general information of patients in the four groups (gender, age, body mass index, living habits, etc.), underlying diseases (hypertension, diabetes), blood test results [uric acid (UA), creatinine (Cre)], urine test results (24-hour urine UA, 24-hour urine Cre) were summarized and the differences between the groups were analyzed. Results: The 200 cases of HUA patients were divided into 54.00% with renal insufficiency type, 38.50% with mixed type, 6.00% with renal overload type, and 1.50% with other types. The age of patients with mixed HUA was younger than that of patients with other types, renal overload type, and renal insufficiency type, and the difference was statistically significant (P < 0.05). The UA level of patients with other types of HUA was lower than that of patients with mixed type HUA, and there was statistical significance (P < 0.05). The Cre level of patients with mixed type HUA was lower than that of patients with renal insufficiency type and renal overload type, and the difference was statistically significant (P < 0.05). The 24-hour urinary UA level in patients with renal insufficiency type HUA was lower than that in patients with renal overload type and mixed type HUA, and the difference was statistically significant (P < 0.05). The 24-hour urinary Cre level of patients with other types of HUA was lower than that of patients with renal overload type and mixed HUA, the difference was statistically significant (P < 0.05). The estimated glomerular filtration rate (eGFR) level of patients with other types of HUA was lower than that of patients with mixed type HUA, and the difference was statistically significant (P < 0.05). There was no significant difference in the proportions of hypertension, diabetes, coronary heart disease, and urinary calculi among patients with renal insufficiency type, renal overload type, mixed type, and other types of HUA (P > 0.05). Conclusion: The primary HUA patients are mainly of renal insufficiency type, followed by mixed type. There are significant differences in the clinical characteristics of patients with different types of HUA. Among them, patients with other types of HUA are the oldest and have the lowest uric acid levels. Patients with mixed HUA had the best renal function but the highest 24-hour urine creatinine level. This study can be used as a basis for rational selection of urate-lowering drugs for different HUA patients.

References

Wang D, Zhang Y, Tian Z, et al., 2022, Evaluation of Methodological Quality and Reporting Quality of Clinical Guidelines for Hyperuricemia in China. Chinese Journal of Traditional Chinese Medicine, 47(2): 547–556.

Chinese Medical Association, Chinese Medical Association Magazine, Chinese Medical Association General Medicine Branch, et al., 2020, Guidelines for Primary Diagnosis and Treatment of Gout and Hyperuricemia (Practice Edition 2019). Chinese Journal of General Practitioners, 19(6): 486–494.

Fan L, Zhou C, Huang W, et al., 2020, Analysis of the Distribution Characteristics of Serum Uric Acid Levels and Hyperuricemia in Healthy People. Marker Immunology Analysis and Clinic, 27(2): 252–256.

Society of Endocrinology, Chinese Medical Association, 2020, Guidelines for Diagnosis and Treatment of Hyperuricemia and Gout in China (2019). Chinese Journal of Endocrinology and Metabolism, 36(1): 1–13.

Diabetes Society of Chinese Medical Association, 2021, Guidelines for Prevention and Treatment of Type 2 Diabetes in China (2020 Edition). Chinese Journal of Diabetes, 13(4): 315–409.

Liu J, Lu X, Chen L, et al., 2020, Consensus Among Young and Middle-Aged Chinese Experts on the Management of Hypertension. Chinese Journal of Hypertension, 28(4): 316–324.

Beijing Association for Prevention and Treatment of Hypertension, Chinese Stroke Society Hypertension Prevention and Management Branch, China Senior Care Association Pension and Health Professional Committee, et al., 2022, Expert Consensus on Co-morbidity Management of Coronary Heart Disease and Ischemic Stroke at Grassroots Level 2022. Prevention and Treatment of Cardiovascular and Cerebrovascular Diseases, 22(4): 1–19.

Li X, Gao L, Chen Y, et al., 2021, Analysis of Risk Factors in Patients with Hyperuricemia. Journal of Clinical Internal Medicine, 38(10): 695–696.

Dai L, Li Q, 2020, Uric Acid-Lowering Drug Treatment for Gout Patients from the Changes of Domestic and Foreign Guidelines in the Past Five Years. Internal Medicine Theory and Practice, 15(4): 216–220.

Zhou B, Chen H, Zhang Z, et al., 2021, Analysis of Etiological Types and Clinical Features of Gout. Chinese Journal of Rheumatology, 25(3): 145–149.